Abstract
Background Since the COVID-19 pandemic has been pestilential over a considerable duration, global deployment and financial crisis could not be reversed as before. It brought up essentials to allow the nations back to work with effective preventive measures. This review intended to evaluate the persistence of SARS-CoV-2(COVID-19) exposed in the environmental matrices, influencing factors on the virus persistence and disinfection methods.
Methods Applying the PRISMA 2020 tool, MEDLINE/PubMed, HINARI, and Google Scholar were primarily explored. Data were extracted, entered into the modified data extraction forms and analysed narratively. Quality appraisal was done by the Mixed-Methods Appraisal Tool. The findings were presented descriptively.
Results Persistence of SARS-CoV-2 was revealed <4 hours on aluminium, 4 hours on copper, 24 hours on cardboard, 44 hours on glass, 48 hours on stainless steel, 72 hours on plastic, 92 hours on polystyrene plastic, 1.1-1.2 hours in the air, 7 days (higher titer) to 3 days(lower titer) in wastewater. Virus decaying was noted 5-10 times faster at 27°C than at 10°C and 2-5 times faster with 65% relative humidity (RH) than with 40% and 100% RH. Virus infectivity was reduced by far-UVC-(222 nm) light for 90%-(8 minutes), 95%-(11 minutes), 99%-(16 minutes) and 99.99%-(25 minutes). Sodium hypochlorite (800 g/m3) and ammonium-based detergents were remarkably effective for preliminary disinfection.
Conclusions This review identified the duration of SARS-CoV-2 survival in environmental matrices for both healthcare and non-healthcare settings. The study explored the impacts of environmental factors on the virus and effective disinfection methods to be considered accordingly to the findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NO
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Details of authors' contacts including phone numbers, emails, and affiliations were mentioned on the cover page of the manuscript for being requested additional information such as the extracted data sheets and tables.
